RxDoctor Payments Data

Vadim Goz, MD

Orthopaedic Surgery of the Spine · Reno, NVNPI 1053739003

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Globus Medical at 42.0% of the total. 2025 is the largest year on record at $8,656, more than ten times the $78 reported in 2019.

$25,304in general payments, 2019–2025

Across 136 payments — averaging $186.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$11K
  • Alphatec Spine, Inc$8K
  • Camber Spine Technologies LLC$3K
  • Stryker$2K
  • Medtronic$434
  • The Institute Of Musculoskeletal Science And Education$307
  • plus $905 from 9 others

What the payments were for

  • Royalty or licence$3071%
  • Consulting fees$11,00043%
  • Travel & lodging$9,65238%
  • Food & beverage$4,34417%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,304 in reported general payments places this provider in the 55th percentile of 30 orthopaedic surgery of the spine providers in Nevada.

See all orthopaedic surgery of the spine providers in Nevada

Medicare billing

Part B allowed, 2024
$287,054
Medicare patients
666
Services billed
1,866

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin80$874
Methylprednisolone47$306
Meloxicam74$142
Cyclobenzaprine Hcl20$104
Oxycodone Hcl11$86

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →